| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cel-Sci Corporation (CVM) has 6 insiders with recent SEC Form 4 filings, including 6 buys and 7 sells. CVM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 222.5K | $231.4K | - | |
| VP | 38.0K | $39.5K | - | |
| Dir | 28.0K | $29.1K | - | |
| Dir | 27.3K | $28.4K | - | |
| CFO | 12.0K | $12.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2019 | Young Peter R | Director | Buy | 2,000 | $5.20 | $10,400.00 | +11.7% | |
| Feb 14, 2019 | Young Peter R | Director | Buy | 1,000 | $2.82 | $2,820.00 | +6.2% | |
| Dec 31, 2018 | Zimmerman Daniel H | Sr. Vice President | Sell | 2,474 | $2.93 | $7,248.82 | -2.3% | |
| May 1, 2018 | Young Peter R | Director | Buy | 2,000 | $2.14 | $4,280.00 | +17.1% | |
| Apr 27, 2018 | Young Peter R | Director | Buy | 4,000 | $2.39 | $9,540.00 | +52.0% | |
| Apr 16, 2018 | Young Peter R | Director | Buy | 6,500 | $1.80 | $11,675.00 | +133.1% | |
| Jan 22, 2018 | Talor Eyal | CSO | Sell | 8,192 | $2.06 | $16,875.52 | -3.5% | |
| Jan 16, 2018 | Talor Eyal | CSO | Sell | 1,808 | $2.15 | $3,887.20 | -0.7% | |
| Aug 25, 2017 | Talor Eyal | Chief Scientific Officer | Sell | 769 | $1.91 | $1,468.79 | -0.6% | |
| Aug 16, 2017 | Cipriano John | Senior Vice President | Sell | 17,109 | $2.52 | $43,114.68 | -26.3% |